Principal, National Sector Leader for HCLS, KPMG US
Healthcare Life Sciences
KPMG is a leader in The Forrester New WaveTM in Healthcare RPA
Payers are increasingly partnering with primary-care organizations to improve patient outcomes.
Unwinding federal COVID-19 policies will have significant industry impacts.
Reforms to FDA Accelerated Approval Program could include new confirmatory study requirements.
Healthcare boards shape strategies around consumerism, attrition, and ESG issues from climate change to boardroom diversity.
Our 2022 Healthcare and Life Sciences Investment Outlook offers a look into industry innovations with the greatest investor interest.
Healthcare organizations need robust identity access management to provide the anytime, anywhere care that today’s patients demand.
Healthcare trends have created opportunities to strategically target pharmacy to make innovative and transformative impact.
ESG in healthcare is a burning platform that includes telling your ESG story and making it synonymous with your brand.
Healthcare payors should take a holistic approach to data governance to maximize valuable insights while minimizing risks.
By prioritizing patient-facing digital health systems during integration, healthcare providers can realize more value sooner.
This paper addresses how government can accelerate and fund the programs that directly address the social drivers of healthcare costs.
Measuring Environmental, Social and Governance: Understanding connectivity to health outcomes and performance.
200 health leaders were surveyed on workforce, digital health, partnerships, patient centricity, and delivery model changes.
How acquirers in home health and hospice can overcome complex market, regulatory, and operational challenges
The rapid pace of technology disruption in the healthcare sector is bringing on new and more pervasive risks.
Healthcare organizations have opportunities to use artificial intelligence to improve productivity, reduce risk, and save lives.
For payors evolving toward becoming “healthcare partners,” this paper covers six trends to watch in 2021.
Learn how your healthcare organization can address the growing threat of more insidious cyber-security attacks.
The American Rescue Plan Act of 2021 expands healthcare coverage and provides pandemic funding.
Provides insights on how the political and regulatory environment, and market factors may impact investment decisions.
Biden Administration could increase Medicare audit and enforcement in the years ahead: a review of the data
Drawing on survey insights, we highlight the five areas that audit and compliance committee chairs rank as top priorities.
HHS proposed modifying HIPAA rules governing sharing, privacy, and security of personal health information
CMS and ONC proposed rule aims to improve health data exchange and streamline prior authorization
On November 20, 2020, the Centers for Medicare and Medicaid Services announced the Most Favored Nation Drug Pricing Model.
HHS, Department of Labor, and Treasury finalized price transparency requirements for health plans set to take effect beginning in 2022.
Global insights, practical advice, and tools to help healthcare leaders build and sustain a resilient new reality.
High performing healthcare organizations need to evolve key capabilities and make technological investments to build on the digital momentum.
FDA finalized a rule and guidance allowing states to submit prescription drug importation proposals and manufacturers to re-label drugs for importation.
Several price transparency requirements for hospitals and health plans take effect in 2021; stakeholders must prepare
An Executive Order directs HHS rulemaking for “most favored nations” pricing for Medicare Part B and D drugs.
As telemedicine accelerates, the need for greater tax clarity and updated guidance relating to virtual healthcare is evident.
Four Executive Orders (EO) described as action to deliver lower prescription drug prices to American Patients.
Health systems’ future growth strategies must align with the ways in which COVID-19 has changed healthcare delivery.
Healthcare provider organizations are facing financial and operational challenges as a result of COVID-19.
As demand for telehealth grows during the COVID-19 pandemic, CMS must consider what flexibilities can or should be extended.
Access to telehealth services in Medicare has been expanded in response to COVID-19, but those changes may not be permanent.
Although healthcare organizations are focused on fighting COVID-19, the need for ongoing cyber security should not be underestimated.
Private labs seeking to restructure or build to deploy COVID-19 testing operations can benefit from KPMG’s rapid start-up approach.
Virtual care is proving to be a critical tool in the fight against COVID-19. For more on how to get up and running
For businesses making decisions about when and how to reopen their businesses, here is a practical guide to key considerations.
Implications for Healthcare providers.
The power of data and emerging technology
A digital pathway
HHS has announced plans to distribute the remaining $70 billion in CARES Act relief funds to providers; for more information
For guidance on how providers can pivot their internal audit plans to help give order to their organizations during COVID-19
As healthcare providers battle COVID-19, they may need help balancing compliance obligations. For more on what to expect
For guidance on how to align supplies, medical personnel and clinical operations with the different stages of COVID-19
For insight into how COVID-related payer guidelines and government regulations can impact the your revenue cycle
CMS just announced alternative Part D options that lower seniors’ cost-sharing for insulin, according to the attached issue brief.
To learn how CMS is offering health systems greater flexibility and critical waivers during the COVID-19 crisis
For an overview of how to navigate the new COVID-19 coding guidance, going into effect on April 1, 2020
To learn more about enhancements to CMS’s Accelerated & Advance Payment Program to help providers & suppliers during COVID.
Economic support and stimulus bill.
Taking the temperature of artificial intelligence in healthcare
Analysis of the 2020 KPMG Healthcare and Life Sciences Investment Outlook survey sheds light on how the investment landscape will be impacted by influential disruptors, evolving market trends, and policy/regulatory developments.
Prioritizing a heavy healthcare audit and compliance committee (audit committee) agenda is never easy, and 2020 will be particularly challenging.
Prioritizing a heavy healthcare board agenda is never easy, and 2020 will be particularly challenging.
Patients have more choice than ever about where and when they seek care.
The healthcare revenue cycle is ripe for productivity gains and cost reduction. Forward-reaching organizations are effecting real change with connected robotic process automation.
Medicare Shared Savings Program
Mandated or not, transparency is table stakes in a consumer-centric healthcare system
Building a culture of excellence in healthcare
CMS and ONC proposed rules on the exchange of health information
Apply to participate in value-based insurance design model
By 2030, a consumer-centric healthcare system will be an imperative. Here’s how to get there.
Board and audit committee agendas should continue to evolve in 2019 amid the game-changing implications of technology, consolidation, and new entrants.
2019 Health Care & Life Sciences Investment Outlook.
Cost transformation today lays the groundwork for innovation tomorrow.
Identifying opportunities for life sciences manufacturers.
Driving value in healthcare
Finance disrupted - As the industry adjusts to continuous disruption, the finance function has an opportunity to lead
As new entrants and cross-sector models abound, which direction should healthcare organizations turn?
Aligning MACRA payment model development with CMMI priorities
Healthcare providers and payers need to up their IT game. The clock is ticking
The industry’s stance on the Cloud is transitioning from fear to optimism
Rethinking public private partnerships for universal healthcare
The 2019 Medicare Part C&D Programs proposed rule
Healthcare and life sciences will face continued disruption in 2018 as new technologies, economic pressures and consumer/patient demands change the industry.
Extended flexibility on the path to value-based payments
The 2019 ACA Marketplace proposed rule
Care Continuum Optimization can minimize clinical variation to drive real quality in healthcare
While healthcare reform developments continue, no legislation has been enacted. Understand the “state of the union” from a tax perspective.
Health system checkup
For data-intensive healthcare, cyber security is integral to innovation
Hospitals and health systems have a renewed focus on profitable organic growth.
Results from the KPMG-AMA Survey
Taxes and the Better Care Reconciliation Act of 2017
The unfinished health IT agenda
The U.S. House of Representatives passed H.R. 1628, the American Health Care Act of 2017 (AHCA), by a vote of 217-212. A portion of the bill, which repeals and modifies a number of provisions of the Affordable Care Act, was previously reported by the Ways and Means Committee on a party-line vote on March 9, 2017.
Hospitals increase revenue recovery with robotic process automation
A practical path to improving healthcare through transparency
Develop mutually beneficial relationships between industry and patient representative bodies
Learn the 5 high impact areas one should use to assess their organization.
Forward-thinking life sciences companies may want to consider the impact of potential tax reform on their supply chain, R&D and more
Developing a dynamic strategy in a changing healthcare environment
Analysis that matters from Washington National Tax
The HHS proposed rule to stabilize the marketplace
Register to receive timely insights
Meet our team